Treatment | Dosages (ug/mL) | PL | SVI | ||
---|---|---|---|---|---|
72 Hrs | 120Hrs | 72 Hrs | 120 Hrs | ||
No-treatment control | 0 | 2.34 ± 0.65 | 2.97 ± 0.34 | 172.45 ± 9.3 | 201.8 ± 8.1 |
Saliva | 150 | 2.07 ± 0.61 | 1.99 ± 0.48 | 135.3 ± 8.8 | 69.65 ± 6.9 |
450 | 2.01 ± 0.47 | 1.81 ± 0.66 | 105.9 ± 6.9 | 50.68 ± 5.3 | |
Hemolymph | 150 | 2.00 ± 0.80 | 1.76 ± 0.42 | 118.6 ± 5.1 | 59.40 ± 7.7 |
450 | 1.85 ± 0.25 | 1.35 ± 0.57 | 77.19 ± 7.8 | 47.73 ± 4.4 | |
Positive control-Glucantime | 50 | 1.91 ± 0.48 | 1.41 ± 0.48 | 97.07 ± 5.7 | 41.04 ± 5.5 |
100 | 1.79 ± 0.36 | 1.33 ± 0.39 | 68.48 ± 3.5 | 21.82 ± 3.1 |